• Home
  • Corporate Members
  • Exhibit Hall
  • About
  • Conference
  • Previous Conferences
    • WSMOS COVID-19 – June 25, 2020
    • WSMOS TeleHealth – July 2, 2020
    • WSMOS COVID-19 – UPDATES – October 29, 2020
  • Agenda
  • Contact
  • Join Now
  • Home
  • About us
  • Our services
  • Our clients
  • Contact

Please don’t hesitate to email director@wsmosconference.org or complete the contact form.

Send a Request
© 2020 WSMOS Conference. All Rights Reserved. Disclaimers
      This browser is no longer recommended for use by Microsoft. To optimize your security and experience on WSMOSCONFERENCE website, we suggest using Google Chrome, Firefox or Microsoft Edge.

      Company Overview

      For more than a century, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Today, Merck continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.

      During this unprecedented time, Merck is committed to ensuring our medicines and vaccines reach our patients and customers. This includes supporting patients who might need more help today with their medications, including those who may have lost insurance coverage, or may not be able to afford their medication due to the COVID-19 pandemic.

      To learn about what support options may be available to eligible patients visit our Access and Patient Assistance information page. https://www.merck.com/product/access-and-patient-assistance.html

      For more details about Merck’s response to coronavirus, visit our COVID-19 information page. http://www.merck.com/covid-19 This content is intended for health care professionals of the United States, its territories, and Puerto Rico.

      Company Overview

      Kyowa Kirin is a global specialty pharmaceutical company with US Headquarters based in Bedminster, NJ. The company is focused primarily on developing and commercializing biopharmaceuticals that help improve the health and well-being of people through innovative and state-of-the-art technologies in various therapeutic areas including oncology, neurology, nephrology, and immunology. For additional information, you can visit us at www.kyowakirin.com.

      abbvie

      I Would Like Someone to Get in Touch With Me

      abbvie

      I Would Like Someone to Get in Touch With Me

      Company Overview

      EUSA Pharma is a dynamic, global biopharmaceutical company focused on oncology and rare disease, continuously striving to confront gaps in patient care. Our ambition drives us to deliver medical treatments that deliver real change to improve lives wherever they are needed in the world. As a young, specialty pharmaceutical company, EUSA Pharma is committed to delivering solutions that can have a meaningful effect on life, helping patients across a range of therapy areas.

      astellas

      I Would Like Someone to Get in Touch With Me

      epizyme

      I Would Like Someone to Get in Touch With Me

      Company Overview

      BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 4,000+ employees in China, the United States, Australia, and Europe are committed to expediting the development of a diverse pipeline of novel therapeutics for cancer. We currently market an internally-discovered product, BRUKINSA® (zanubrutinib) in the United States.

      beigene

      I Would Like Someone to Get in Touch With Me

      Company Overview

      Epizyme, Inc. is a fully integrated biopharmaceutical company committed to rewriting treatment for cancer and other serious diseases through transformative epigenetic medicines. In addition to a robust research and discovery pipeline, Epizyme has one commercial oncology product and is exploring the treatment potential of this therapy in investigational clinical trials focused on other conditions. By focusing on the genetic drivers of disease, Epizyme works to match new medicines with the patients who need them. For more information, visit www.epizyme.com.